Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Medical Enzyme Technology Market


4. Market Overview

4.1. Definition

4.2. Market Indicators

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, 2018–2030

4.5. Global Medical Enzyme Technology Market Outlook


5. Key Insights

5.1. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)

5.2. Technological Advancements

5.3. Major Research Institutes Involved

5.4. Disease Prevalence & Incidence Rate Globally in Key Countries

5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)


6. Global Medical Enzyme Technology Market Analysis and Forecast, by Enzyme Type

6.1. Introduction

6.2. Global Medical Enzyme Technology Market Value Share Analysis, by Enzyme Type

6.3. Global Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2018–2030

6.3.1. Digestive Enzymes

6.3.1.1. L-asparginase

6.3.1.2. Lactase

6.3.1.3. Others

6.3.2. Thrombolytic Enzymes

6.3.2.1. Streptokinase

6.3.2.2. Urokinase

6.3.2.3. Others

6.3.3. Hydrolases

6.3.3.1. Hyaluronidase

6.3.3.2. Lysozyme

6.3.3.3. Others

6.3.4. Others

6.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Enzyme Type


7. Global Medical Enzyme Technology Market Analysis and Forecast, by Application

7.1. Introduction

7.2. Global Medical Enzyme Technology Market Value Share Analysis, by Application

7.3. Global Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

7.3.1. Disease Treatment

7.3.1.1. Cancer (Chemotherapy)

7.3.1.2. Metabolic Diseases

7.3.1.3. Others

7.3.2. Diagnostic Tools

7.3.2.1. Renal Disease

7.3.2.2. Cancer

7.3.2.3. Others

7.3.3. Biomedical Research

7.3.4. Others

7.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Application


8. Global Medical Enzyme Technology Market Analysis and Forecast, by Region

8.1. Regional Outlook

8.2. Introduction

8.3. Global Medical Enzyme Technology Market Value Forecast, by Region

8.3.1. North America

8.3.2. Europe

8.3.3. Asia Pacific

8.3.4. Latin America

8.3.5. Middle East & Africa

8.4. Global Medical Enzyme Technology Market Attractiveness Analysis, by Region


9. North America Medical Enzyme Technology Market Analysis and Forecast

9.1. Key Findings

9.2. North America Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2018–2030

9.2.1. Digestive Enzymes

9.2.1.1. L-asparginase

9.2.1.2. Lactase

9.2.1.3. Others

9.2.2. Thrombolytic Enzymes

9.2.2.1. Streptokinase

9.2.2.2. Urokinase

9.2.2.3. Others

9.2.3. Hydrolases

9.2.3.1. Hyaluronidase

9.2.3.2. Lysozyme

9.2.3.3. Others

9.2.4. Others

9.3. North America Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

9.3.1. Disease Treatment

9.3.1.1. Cancer (Chemotherapy)

9.3.1.2. Metabolic Diseases

9.3.1.3. Others

9.3.2. Diagnostic Tools

9.3.2.1. Renal Disease

9.3.2.2. Cancer

9.3.2.3. Others

9.3.3. Biomedical Research

9.3.4. Others

9.4. North America Medical Enzyme Technology Market Value Forecast, by Country, 2018–2030

9.4.1. U.S.

9.4.2. Canada

9.5. North America Medical Enzyme Technology Market Attractiveness Analysis

9.5.1. By Enzyme Type

9.5.2. By Application

9.5.3. By Country


10. Europe Medical Enzyme Technology Market Analysis and Forecast

10.1. Key Findings

10.2. Europe Medical Enzyme Technology Market Value Forecast, by Enzyme Type, 2018–2030

10.2.1. Digestive Enzymes

10.2.1.1. L-asparginase

10.2.1.2. Lactase

10.2.1.3. Others

10.2.2. Thrombolytic Enzymes

10.2.2.1. Streptokinase

10.2.2.2. Urokinase

10.2.2.3. Others

10.2.3. Hydrolases

10.2.3.1. Hyaluronidase

10.2.3.2. Lysozyme

10.2.3.3. Others

10.2.4. Others

10.3. Europe Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

10.3.1. Disease Treatment

10.3.1.1. Cancer (Chemotherapy)

10.3.1.2. Metabolic Diseases

10.3.1.3. Others

10.3.2. Diagnostic Tools

10.3.2.1. Renal Disease

10.3.2.2. Cancer

10.3.2.3. Others

10.3.3. Biomedical Research

10.3.4. Others

10.4. Europe Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018–2030

10.4.1. U.K.

10.4.2. Germany

10.4.3. France

10.4.4. Italy

10.4.5. Spain

10.4.6. Rest of Europe

10.5. Europe Medical Enzyme Technology Market Attractiveness Analysis

10.5.1. By Enzyme Type

10.5.2. By Application

10.5.3. By Country/Sub-region

11. Asia Pacific Medical Enzyme Technology Market Analysis and Forecast

11.1. Key Findings

11.2. Asia Pacific Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2018-2030

11.2.1. Digestive Enzymes

11.2.1.1. L-asparginase

11.2.1.2. Lactase

11.2.1.3. Others

11.2.2. Thrombolytic Enzymes

11.2.2.1. Streptokinase

11.2.2.2. Urokinase

11.2.2.3. Others

11.2.3. Hydrolases

11.2.3.1. Hyaluronidase

11.2.3.2. Lysozyme

11.2.3.3. Others

11.2.4. Others

11.3. Asia Pacific Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

11.3.1. Disease Treatment

11.3.1.1. Cancer (Chemotherapy)

11.3.1.2. Metabolic Diseases

11.3.1.3. Others

11.3.2. Diagnostic Tools

11.3.2.1. Renal Disease

11.3.2.2. Cancer

11.3.2.3. Others

11.3.3. Biomedical Research

11.3.4. Others

11.4. Asia Pacific Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018–2030

11.4.1. China

11.4.2. India

11.4.3. Japan

11.4.4. Australia & New Zealand

11.4.5. Rest of Asia Pacific

11.5. Asia Pacific Medical Enzyme Technology Market Attractiveness Analysis

11.5.1. By Enzyme Type

11.5.2. By Application

11.5.3. By Country/Sub-region

12. Latin America Medical Enzyme Technology Market Analysis and Forecast

12.1. Key Findings

12.2. Latin America Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2018-2030

12.2.1. Digestive Enzymes

12.2.1.1. L-asparginase

12.2.1.2. Lactase

12.2.1.3. Others

12.2.2. Thrombolytic Enzymes

12.2.2.1. Streptokinase

12.2.2.2. Urokinase

12.2.2.3. Others

12.2.3. Hydrolases

12.2.3.1. Hyaluronidase

12.2.3.2. Lysozyme

12.2.3.3. Others

12.2.4. Others

12.3. Latin America Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

12.3.1. Disease Treatment

12.3.1.1. Cancer (Chemotherapy)

12.3.1.2. Metabolic Diseases

12.3.1.3. Others

12.3.2. Diagnostic Tools

12.3.2.1. Renal Disease

12.3.2.2. Cancer

12.3.2.3. Others

12.3.3. Biomedical Research

12.3.4. Others

12.4. Latin America Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018–2030

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Rest of Latin America

12.5. Latin America Medical Enzyme Technology Market Attractiveness Analysis

12.5.1. By Enzyme Type

12.5.2. By Application

12.5.3. By Country/Sub-region


13. Middle East & Africa Medical Enzyme Technology Market Analysis and Forecast

13.1. Key Findings

13.2. Middle East & Africa Medical Enzyme Technology Market Value Forecast, By Enzyme Type, 2018-2030

13.2.1. Digestive Enzymes

13.2.1.1. L-asparginase

13.2.1.2. Lactase

13.2.1.3. Others

13.2.2. Thrombolytic Enzymes

13.2.2.1. Streptokinase

13.2.2.2. Urokinase

13.2.2.3. Others

13.2.3. Hydrolases

13.2.3.1. Hyaluronidase

13.2.3.2. Lysozyme

13.2.3.3. Others

13.2.4. Others

13.3. Middle East & Africa Medical Enzyme Technology Market Value Forecast, by Application, 2018–2030

13.3.1. Disease Treatment

13.3.1.1. Cancer (Chemotherapy)

13.3.1.2. Metabolic Diseases

13.3.1.3. Others

13.3.2. Diagnostic Tools

13.3.2.1. Renal Disease

13.3.2.2. Cancer

13.3.2.3. Others

13.3.3. Biomedical Research

13.3.4. Others

13.4. Middle East & Africa Medical Enzyme Technology Market Value Forecast, by Country/Sub-region, 2018–2030

13.4.1. GCC Countries

13.4.2. South Africa

13.4.3. Rest of Middle East & Africa

13.5. Middle East & Africa Medical Enzyme Technology Market Attractiveness Analysis

13.5.1. By Enzyme Type

13.5.2. By Application

13.5.3. By Country/Sub-region


14. Competition Landscape

14.1. Market Player - Competition Matrix (by Tier and Size of Companies)

14.2. Market Share Analysis, by Company, 2019

14.3. Company Profiles

14.3.1. Thermo Fisher Scientific Inc.

14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.1.2. Financial Overview

14.3.1.3. Product Portfolio

14.3.1.4. Strategic Overview

14.3.1.5. SWOT Analysis

14.3.2. Merck KGaA

14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.2.2. Financial Overview

14.3.2.3. Product Portfolio

14.3.2.4. Strategic Overview

14.3.2.5. SWOT Analysis

14.3.3. Genzyme Corporation (Sanofi)

14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.3.2. Financial Overview

14.3.3.3. Product Portfolio

14.3.3.4. Strategic Overview

14.3.3.5. SWOT Analysis

14.3.4. Promega Corporation

14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.4.2. Financial Overview

14.3.4.3. Product Portfolio

14.3.4.4. Strategic Overview

14.3.4.5. SWOT Analysis

14.3.5. Asahi Kasei Corporation

14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.5.2. Financial Overview

14.3.5.3. Product Portfolio

14.3.5.4. Strategic Overview

14.3.5.5. SWOT Analysis

14.3.6. Takeda Pharmaceutical Company Limited

14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.6.2. Financial Overview

14.3.6.3. Product Portfolio

14.3.6.4. Strategic Overview

14.3.6.5. SWOT Analysis

14.3.7. Cytiva (Danaher)

14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.7.2. Financial Overview

14.3.7.3. Product Portfolio

14.3.7.4. Strategic Overview

14.3.7.5. SWOT Analysis

14.3.8. Agilent Technologies, Inc.

14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.8.2. Financial Overview

14.3.8.3. Product Portfolio

14.3.8.4. Strategic Overview

14.3.8.5. SWOT Analysis

14.3.9. Sun Pharmaceutical Industries Ltd.

14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.9.2. Financial Overview

14.3.9.3. Product Portfolio

14.3.9.4. Strategic Overview

14.3.9.5. SWOT Analysis

14.3.10. Amano Enzyme Inc.

14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.10.2. Financial Overview

14.3.10.3. Product Portfolio

14.3.10.4. Strategic Overview

14.3.10.5. SWOT Analysis

14.3.11. Novozymes A/S

14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.11.2. Financial Overview

14.3.11.3. Product Portfolio

14.3.11.4. Strategic Overview

14.3.11.5. SWOT Analysis



List of Figures



Figure 01: Global Medical Enzyme Technology Market

Figure 02: Global Medical Enzyme Technology Market Value (US$ Mn) by Region, 2019 and 2030

Figure 03: Global Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2030

Figure 04: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2020

Figure 05: Global Medical Enzyme Technology Market Value Share, by Application, 2020

Figure 06: Global Medical Enzyme Technology market Value Share, by Region, 2020

Figure 08: Global Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020–2030

Figure 07: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030

Figure 09: Global Medical Enzyme Technology Market Value Share, by Digestive Enzymes, 2019 and 2030

Figure 10: Global Medical Enzyme Technology Market Attractiveness, by Digestive Enzymes, 2020–2030

Figure 11: Global Medical Enzyme Technology Market Value Share, by Thrombolytic Enzymes, 2019 and 2030

Figure 12: Global Medical Enzyme Technology Market Attractiveness, by Thrombolytic Enzymes, 2020–2030

Figure 13: Global Medical Enzyme Technology Market Value Share, by Hydrolases, 2019 and 2030

Figure 14: Global Medical Enzyme Technology Market Attractiveness, by Hydrolases, 2020–2030

Figure 15: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Digestive Enzymes, 2018–2030

Figure 16: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Thrombolytic Enzymes, 2018–2030

Figure 17: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hydrolases, 2018–2030

Figure 18: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018–2030

Figure 19: Global Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030

Figure 20: Global Medical Enzyme Technology Market Attractiveness, by Application, 2020–2030

Figure 21: Global Medical Enzyme Technology Market Value Share, by Disease Treatment, 2019 and 2030

Figure 22: Global Medical Enzyme Technology Market Attractiveness, by Disease Treatment, 2020–2030

Figure 23: Global Medical Enzyme Technology Market Value Share, by Diagnostic Tools, 2019 and 2030

Figure 24: Global Medical Enzyme Technology Market Attractiveness, by Diagnostic Tools, 2020–2030

Figure 25: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Disease Treatment, 2018–2030

Figure 26: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Tools, 2018–2030

Figure 27: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biomedical Research, 2018–2030

Figure 28: Global Medical Enzyme Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2018–2030

Figure 29: Medical Enzyme Technology Market: Regional Outlook

Figure 30: Global Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth Rate (%) Forecast, 2018–2030

Figure 31: Global Medical Enzyme Technology Market Value Share, by Region, 2019 and 2030

Figure 32: Global Medical Enzyme Technology Market Attractiveness, by Region, 2020–2030

Figure 33: North America Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2030

Figure 34: Global Medical Enzyme Technology Market Value Share, by Country, 2019 and 2030

Figure 35: Global Medical Enzyme Technology Market Attractiveness, by Country, 2020–2030

Figure 36: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030

Figure 37: Global Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020–2030

Figure 38: Global Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030

Figure 39: Global Medical Enzyme Technology Market Attractiveness, by Application, 2020–2030

Figure 40: Europe Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2030

Figure 41: Global Medical Enzyme Technology Market Value Share, by Country/Sub-region, 2019 and 2030

Figure 42: Global Medical Enzyme Technology Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 43: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030

Figure 44: Global Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020–2030

Figure 45: Global Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030

Figure 46: Global Medical Enzyme Technology Market Attractiveness, by Application, 2020–2030

Figure 47: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2030

Figure 48: Global Medical Enzyme Technology Market Value Share, by Country/Sub-region, 2019 and 2030

Figure 49: Global Medical Enzyme Technology Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 50: Global Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030

Figure 51: Global Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020–2030

Figure 52: Global Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030

Figure 53: Global Medical Enzyme Technology Market Attractiveness, by Application, 2020–2030

Figure 54: Latin America Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2030

Figure 55: Latin America Medical Enzyme Technology Market Value Share, by Country/Sub-region, 2019 and 2030

Figure 56: Latin America Medical Enzyme Technology Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 57: Latin America Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030

Figure 58: Latin America Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020–2030

Figure 59: Latin America Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030

Figure 60: Latin America Medical Enzyme Technology Market Attractiveness, by Application, 2020–2030

Figure 61: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2030

Figure 62: Middle East & Africa Medical Enzyme Technology Market Value Share, by Country/Sub-region, 2019 and 2030

Figure 63: Middle East & Africa Medical Enzyme Technology Market Attractiveness, by Country/Sub-region, 2020–2030

Figure 64: Middle East & Africa Medical Enzyme Technology Market Value Share, by Enzyme Type, 2019 and 2030

Figure 65: Middle East & Africa Medical Enzyme Technology Market Attractiveness, by Enzyme Type, 2020–2030

Figure 66: Middle East & Africa Medical Enzyme Technology Market Value Share, by Application, 2019 and 2030

Figure 67: Middle East & Africa Medical Enzyme Technology Market Attractiveness, by Application, 2020–2030

Figure 68: Global Medical Enzyme Technology Market Analysis, by Top Company Ranking, 2019


List of Tables



Table 01: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018–2030

Table 02: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018–2030

Table 03: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018–2030

Table 04: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018–2030

Table 05: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 06: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018–2030

Table 07: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018–2030

Table 08: Global Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 09: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 10: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018–2030

Table 11: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018–2030

Table 12: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018–2030

Table 13: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018–2030

Table 14: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 15: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018–2030

Table 16: North America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018–2030

Table 17: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 18: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018–2030

Table 19: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018–2030

Table 20: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018–2030

Table 21: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018–2030

Table 22: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 23: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018–2030

Table 24: Europe Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018–2030

Table 25: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 26: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018–2030

Table 27: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018–2030

Table 28: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018–2030

Table 29: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018–2030

Table 30: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 31: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018–2030

Table 32: Asia Pacific Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018–2030

Table 33: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 34: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018–2030

Table 35: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018–2030

Table 36: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018–2030

Table 37: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018–2030

Table 38: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 39: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018–2030

Table 40: Latin America Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018–2030

Table 41: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 42: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Enzyme Type, 2018–2030

Table 43: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Digestive Enzymes, 2018–2030

Table 44: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Thrombolytic Enzymes, 2018–2030

Table 45: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Hydrolases, 2018–2030

Table 46: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Application, 2018–2030

Table 47: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Disease Treatment, 2018–2030

Table 48: Middle East & Africa Medical Enzyme Technology Market Value (US$ Mn) Forecast, by Diagnostic Tools, 2018–2030